Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,

Slides:



Advertisements
Similar presentations
T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Advertisements

Polyps – Where do they come from and what do you do with them?!
State-of-the-art in the Surgical Treatment of Gastric Cancer in Shanghai Department of Surgery Rui Jin Hospital School of Medicine, SJTU.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Endoscopic Mucosal Resection Dr. Howard Mertz Clinical Assistant Professor Vanderbilt University Saint Thomas Hospital Nashville TN.
Management of large rectal adenoma Dr. Hester YS Cheung Department of surgery Pamela Youde Nethersole Eastern Hospital.
The Adenoma/Carcinoma Sequence in the Colon
Management of Difficult Colonic Lesions
How to get more nodes in laparoscopic colon surgery John Marks MD Chief Division of Colorectal Surgery Lankenau Hospital and Institute of Medical Research.
RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT OF EARLY GASTRIC CANCER
Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.
Malignant colonic polyp: endoscopic treatment updates
Dr. LF Hung Department of Surgery, Tuen Mun Hospital, HKSAR
Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian,
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
Unit of Gastrenterology Unit of Endocrinology THEAGENIO Hospital, Thessaloniki Metastatic neuroendocrine tumor of the jejunum-ileum.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
53 y/o Upper abd pain/burning, reflux 9/2011 – EGD – polypoid lesion in stomach on EGD, started on omeprazole – Path – carcinoid, invasive to muscularis,
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
MALIGNANT POLYPS DURING THE FIRST THREE SCREENING ROUNDS ( ) FOR COLON-RECTAL CANCER (CRC) IN A NORTH-EASTERN SANITARY DISTRICT (ULSS-1 VENETO).
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and.
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma JIN Chen, YAO Lie, LONG.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 5 : 2013 F1 김태영 Katsuhiko Higuchi, MD, PhD, Satoshi Tanabe, MD, PhD, Mizutomo Azuma, MD, PhD, Chikatoshi Katada,
1 Motohiko Kato, Tsutomu Nishida, Katsumi Yamamoto, Shiro Hayashi, Shinji Kitamura, Takamasa,Yabuta, Toshiyuki Yoshio, Takeshi Nakamura, Masato Komori,6.
GI conference Case 3 Stomach and liver F/69 S
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Eradication of Helicobacter pylori After Endoscopic Resection of Gastric Tumors Does Not Reduce Incidence of Metachronous Gastric Carcinoma Clinical Gastroenterology.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Long-term outcomes of endoscopic submucosal dissection (ESD) for superficial esophageal squamous cell neoplasms Satoshi Ono, MD, Mitsuhiro Fujishiro, MD,
Ryonho Koh, MD,1 Kingo Hirasawa, MD,1 Sei Yahara, MD,1 Hiroyuki Oka, MD,1 Kazuya Sugimori, MD,1 Manabu Morimoto, MD,1 Kazushi Numata, MD,1 Atsushi Kokawa,
Review R4 황은정 / prof. 장영운 경희대학교 의과대학 소화기내과.
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Hye Won Lee Hyuk Lee Hyunsoo Chung Jun Chul Park Sung Kwan Shin Sang Kil Lee Young Chan Lee Jung Hwa Hong Dong Wook Kim The efficacy of single-dose postoperative.
Comparison Between Definitive Chemoradiotherapy and Esophagectomy in Patients With Clinical Stage I Esophageal Squamous Cell Carcinoma Sachiko Yamamoto MD,
Short-term outcome of neo-adjuvant chemotherapy
Operative Approach and
Date of download: 10/18/2017 Copyright © ASME. All rights reserved.
Department of General Surgery, Upper Gastrointestinal Unit,
Metastatic Disease in the Stomach
Analysis of Incompletely Excised BCCs (4.68%)
Safety and Efficacy of Secondary Endoscopic Submucosal Dissection for Residual Gastric Carcinoma after Primary Endoscopic Submucosal Dissection Digestion.
Audit of Results of Lid Tumour Excision
Contribution by Prof. Dr. B.L.A.M. Weusten
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
American Gastroenterological Association (AGA) Institute Technology Assessment on Image-Enhanced Endoscopy  Tonya Kaltenbach, Yasushi Sano, Shai Friedland,
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Nonpolypoid (Flat and Depressed) Colorectal Neoplasms
Polyps of the Colon and Rectum
Comparison of Surgical Therapy of Gastric Cancer in Japan and Germany
Tonya Kaltenbach, MD, William J. Sandborn, MD 
How to Approach a Patient With Ampullary Lesion
David L. Diehl, MD, FACP, FASGE, Jay P. Babich, MD 
Henning Gerke, MD  Gastrointestinal Endoscopy 
ESD and beyond – The benefits of “getting it early”
Surgical resection of metachronous liver metastases
Presentation transcript:

Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2, Toshiharu Yamaguchi1, Noriko Yamamoto3, Yo Kato3, and Akio Yamaguchi4 1 Department of Surgery, Cancer Institute Hospital, Ariake, Koto-ku, Tokyo , Japan 2 Department of Internal Medicine, Cancer Institute Hospital, Tokyo, Japan 3 Department of Pathology, Cancer Institute Hospital, Tokyo, Japan 4 First Department of Surgery, Faculty of Medicine, University of Fukui, Fukui, Japan Gastric Cancer Vol 8, Aug. 2005

Background EGC (early gastric cancer) –EMR (endoscopic mucosal resection) ↑ by improvement diagnostic device and EMR technique –Laparotomy ↓ and quality of life (QOL) ↑ –incomplete resection  no defined strategy AIM –clarify the incidence of en-bloc and complete resections –evaluate the adequacy of our therapeutic strategy by determining the risk of residual cancer or lymph node metastasis

Patients and methods January 1991 and December pts. who underwent EMR for primary gastric cancer Indications of EMR for gastric cancer –Histologically differentiated-type carcinoma (pap, tub1, tub2) mucosal layer, without ulceration or ulcer scars, <30mm –Undifferentiated-type carcinoma remaining in the intramucosal layer without ulceration or ulcer scars, <5 mm in size, regardless of the lesion’s gross appearance Methodology of EMR –strip biopsy method, HSE solution, cap-fitted aspiration mucosal resection, multi-fragment resection –extended immediately, fixed with pins, reconstruct criteria of complete resection –no cancer exposure to any cut end and the line between normal tissue and the portion denatured

Table 1. Classification of patients with incomplete resection Therapeutic strategy –Intramucosal ca. with lateral residue  F/U, additional endoscopic treatment, surgical resection with LN dissection –Invade the surface of the submucosal layer  choose between close F/U or surgery – massive infiltration of the tumor to submucosal layer  strongly recommend surgical resection with level 2 LN dissection

Results

Table 2. incidence of complete and incomplete resection En-bloc resection 529 pts.(72.9%) 303: f/u, 45: op.

Evaluation of patients with additional surgery 45 (12.9%) of 348 patients, 6.2% of all patients –2 pts.(0.6%) : submucosal ca. –17(81.0%) : en-bloc resection  16 : residual ca. 4(19.0%) : multi-fragmented resection  2 : residual ca.

–Residual ca: 1-mucosal layer 1-sumucosal layer

–Residual ca.: 1-mucosal layer 3-submucosal layer –More macroscopically-depressed type lesions compared to group C –Higher incidence of residual cancer and LN metastasis in group B, C, and D

Details of node-positive patients –1.1% of incomplete EMR, 8.9% of those with additional surgery

Conclusion Group A ; treat using endoscopy  modified gastrectomy >conventional gastrectomy Group B ; additional surgery  further examination Group C & D : absolute indication for surgery Guarantee of strategy for incomplete EMR  improve QOL of EGC patients